Sarepta Therapeutics, Inc. (SRPT) analyst actions
Rating and price-target actions on SRPT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SRPT overview →
7 measured SRPT analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Shareholders to Reach Out | Press release | +0.12% | +1.56% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Stockholders to Reach Out | Press release | -0.12% | +0.41% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Shareholders to Reach Out | Press release | +0.61% | +4.18% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Stockholders to Reach Out | Press release | +1.88% | +0.61% | |
| Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label | Press release | -0.21% | -2.36% | |
| Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne | Press release | -3.71% | -1.18% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Shareholders to Reach Out | Press release | -0.54% | -0.30% |
Keep exploring
More SRPT: earnings → · SEC filings → · SRPT overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NuVasive, Inc. (NUVA) | 1,226 | +0.03% | 51% |
| DENTSPLY SIRONA Inc. (XRAY) | 1,226 | +0.05% | 52% |
| Orthofix Medical Inc. (OFIX) | 1,217 | +0.06% | 51% |
| IMMUNOMEDICS (IMMU) | 1,213 | -0.08% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.